EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PERTUSSIS IN GEORGIA (2016-2024): ANALYSIS OF AGE DISTRIBUTION, VACCINATION STATUS, AND CLINICAL COURSE

Как цитировать

Javakhadze, M., Zakhashvili, K., Tushishvili, T., Kobakhidze, M., Tcholadze, E., & Gegeshidze, T. (2025). EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PERTUSSIS IN GEORGIA (2016-2024): ANALYSIS OF AGE DISTRIBUTION, VACCINATION STATUS, AND CLINICAL COURSE. Сборник научных трудов ТГМУ, 59, 129–133. извлечено от https://journals.4science.ge/index.php/CSW/article/view/5368

Аннотация

Background: Pertussis remains a significant public health concern. In recent years, including the post-pandemic period, an increase in incidence has been observed, along with changes in age distribution and seasonality.

Methods: An epidemiological analysis of pertussis in Georgia was conducted for the years 2016–2024 based on data from the National Center for Disease Control and Public Health (NCDC). Additionally, a clinical analysis was performed using medical records of patients hospitalized with a diagnosis of pertussis at Academician Vakhtang Bochorishvili Clinic, taking into account age and vaccination status. The study is retrospective.

Results: Since the pre-pandemic period, pertussis cases had been increasing, with preservation of characteristic seasonality and age-related patterns dependent on vaccination status. During the pandemic period, incidence declined markedly; however, beginning in 2023, a sharp increase was recorded. Cases were most frequent among children under one year of age, who also predominated among hospitalized patients. Hospitalization primarily affected partially vaccinated and unvaccinated children. With increasing age, the disease tended to present in a milder and more atypical form.

Conclusion: Pertussis continues to pose an important public health challenge. The pertussis vaccine is associated with the bacterial toxin pertactin; it is assumed that, in addition to mutations in circulating strains, the bacterium produces other toxins that may contribute to incomplete vaccine effectiveness. As demonstrated by extensive clinical data, vaccination status is associated with unfavorable laboratory markers and influences disease outcome. Adherence to the vaccination schedule is more critical than vaccine type. Vaccination remains the most effective preventive measure. Maternal immunization should be implemented more widely, including in Georgia, and booster vaccination schedules should be reconsidered.

 

Библиографические ссылки

1. European Centre for Disease Prevention and Control (ECDC). Pertussis - Annual Epidemiological Report 2023. Stockholm: ECDC; 2024.

2. World Health Organization (WHO). Pertussis vaccines: WHO position paper - 2022 update. Weekly Epidemiological Record. 2022;97(50):645-672.

3. European Society for Paediatric Infectious Diseases (ESPID). ESPID position statement on pertussis resurgence in Europe. 2023.

4. Cherry JD, et al. The resurgence of pertussis in the post-COVID-19 era: epidemiology and vaccine considerations. Clinical Infectious Diseases. 2023.

Скачивания

Данные скачивания пока недоступны.